Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
Achilles TherapeuticsJanuary 8, 2021 GMT
Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
London, UK 7 January 2021 – Achilles Therapeutics (“Achilles” or the “Company”), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat multiple types of solid tumours, today announced the appointment of Arjan Roozen as VP, Site Head and General Manager, with responsibility for scaling up Achilles’ manufacturing operations to supply cell therapy products for late-stage clinical studies and commercial supply. Arjan brings over 25 years of experience in the field of advanced therapies and Good Manufacturing Practices (GMP) operations, from early phase to commercial manufacture.